Skip to main content
menu
URMC / Labs / Benjamin Miller Lab / News

 

News

20242023202220212020

New NIH-funded Center Could Soon Reduce the Need for Pharmaceutical Trials on Animals

Tuesday, January 9, 2024

Rochester is one of four NIH-sponsored centers that aims to produce tissue-on-chip devices as FDA-qualified drug development tools. The center aims to develop five Food and Drug Administration–qualified drug development tools related to study barrier functions in disease—interfaces in tissue that are critical for the progression of infection, cancer, and many autoimmune disorders.

Read More: New NIH-funded Center Could Soon Reduce the Need for Pharmaceutical Trials on Animals